Cost Effectiveness of a 21-Gene Recurrence Score Assay Versus Canadian Clinical Practice in Post-Menopausal Women with Early-Stage Estrogen or Progesterone-Receptor-Positive, Axillary Lymph-Node Positive Breast Cancer - Hannouf, M B; Xie, B; Brackstone, M (Pharmacoeconomics, 2014)
et al.